These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
544 related items for PubMed ID: 1628126
1. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. Pauksen K, Duraj V, Ljungman P, Sjölin J, Oberg G, Lönnerholm G, Fridell E, Smedmyr B, Simonsson B. Bone Marrow Transplant; 1992 Jun; 9(6):427-32. PubMed ID: 1628126 [Abstract] [Full Text] [Related]
2. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection. Dennehy PH, Saracen CL, Peter G. Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862 [Abstract] [Full Text] [Related]
3. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K, Nicoara C, Germann D, Matter L. Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837 [Abstract] [Full Text] [Related]
8. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps]. Schettini F, Manzionna MM, De Mattia D, Amendola F, Di Bitonto G. Minerva Pediatr; 1989 Mar 25; 41(3):117-22. PubMed ID: 2747598 [Abstract] [Full Text] [Related]
10. Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston- Zagreb strains of measles virus. Mirchamsy H, Nilforoushan MA, Shafyi A, Razavi J, Ashtiani MP, Youssofi I, Sassani A, Fateh G, Nassiri S. Kitasato Arch Exp Med; 1991 Sep 25; 64(2-3):141-7. PubMed ID: 1811112 [Abstract] [Full Text] [Related]
12. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. Ljungman P, Fridell E, Lönnqvist B, Bolme P, Böttiger M, Gahrton G, Linde A, Ringdén O, Wahren B. J Infect Dis; 1989 Apr 25; 159(4):610-5. PubMed ID: 2647859 [Abstract] [Full Text] [Related]
13. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children. Kanesaki T, Baba K, Tsuda N, Yabuuchi H, Yamanishi K, Takahashi M. Biken J; 1986 Dec 25; 29(3-4):63-71. PubMed ID: 3304276 [Abstract] [Full Text] [Related]
14. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine. André FE, Peetermans J. Dev Biol Stand; 1986 Dec 25; 65():101-7. PubMed ID: 3556770 [Abstract] [Full Text] [Related]
17. Measles, mumps, rubella antibody surveillance: pilot study in Grampian, Scotland. Narayan KM, Moffat MA. Health Bull (Edinb); 1992 Jan 25; 50(1):47-53. PubMed ID: 1612895 [Abstract] [Full Text] [Related]
18. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old]. Vázquez Fernández E, López Rois F, Vázquez Carrete JA, Gómez Tato B, Alvarez Ares M. An Esp Pediatr; 1987 Jul 25; 27(1):27-31. PubMed ID: 3662251 [Abstract] [Full Text] [Related]
19. Evaluation of mumps antibodies after measles-mumps-rubella (MMR) vaccines. Ozaki K, Kuno-Sakai H, Kimura M. Tokai J Exp Clin Med; 1987 Dec 25; 12(5-6):305-11. PubMed ID: 3508655 [Abstract] [Full Text] [Related]